Ipilimumab augments antitumor activity of bispecific antibody-armed T cells

Title
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
Authors
Keywords
Ipilimumab, Cytotoxic T-lymphocyte antigen-4 (CTLA-4), Bispecific antibody, Pancreatic cancer, Colorectal cancer, Burkitt’s lymphoma, Activated T cells, Immunotherapy
Journal
Journal of Translational Medicine
Volume 12, Issue 1, Pages 191
Publisher
Springer Nature
Online
2014-07-09
DOI
10.1186/1479-5876-12-191

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now